529 related articles for article (PubMed ID: 15754035)
1. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
Buchwald PC; Westin G; Akerström G
Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and the parathyroid.
Beckerman P; Silver J
Am J Med Sci; 1999 Jun; 317(6):363-9. PubMed ID: 10372835
[TBL] [Abstract][Full Text] [Related]
6. [Population genetic correlation of vitamin D receptor polymorphisms with clinical disorders].
Gyórffy B; Szabó A; Vásárhelyi B
Orv Hetil; 2003 Oct; 144(41):2011-5. PubMed ID: 14631893
[TBL] [Abstract][Full Text] [Related]
7. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor ligands for osteoporosis.
Cheskis BJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
10. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
[TBL] [Abstract][Full Text] [Related]
11. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
Brown AJ; Ritter CS; Knutson JC; Strugnell SA
Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
[TBL] [Abstract][Full Text] [Related]
12. Physiological importance of vitamin D metabolism.
Haussler MR; Chandler JS; Pike JW; Brumbaugh PF; Speer DP; Pitt MJ
Prog Biochem Pharmacol; 1980; 17():134-42. PubMed ID: 6259650
[TBL] [Abstract][Full Text] [Related]
13. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
[TBL] [Abstract][Full Text] [Related]
14. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.
Silver J; Naveh-Many T; Mayer H; Schmelzer HJ; Popovtzer MM
J Clin Invest; 1986 Nov; 78(5):1296-301. PubMed ID: 3771798
[TBL] [Abstract][Full Text] [Related]
15. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K
J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the understanding of the metabolism and functions of vitamin D.
Ross FP; Henry HL
Clin Orthop Relat Res; 1980 Jun; (149):249-67. PubMed ID: 6250754
[TBL] [Abstract][Full Text] [Related]
17. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
Korkor AB
N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
[TBL] [Abstract][Full Text] [Related]
18. VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3.
Baroni E; Biffi M; Benigni F; Monno A; Carlucci D; Carmeliet G; Bouillon R; D'Ambrosio D
J Leukoc Biol; 2007 Jan; 81(1):250-62. PubMed ID: 17035339
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
20. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
Nezbedova P; Brtko J
Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
